Cas9 editing has been used in vivo for the first time as part of a treatment to restore sight to those with an inherited form of congenital blindness.
(source: biotechniques.com)
Cas9 editing has been used in vivo for the first time as part of a treatment to restore sight to those with an inherited form of congenital blindness.
(source: biotechniques.com)